Red flags that end the comparison

What makes an offer worth pausing over

1. No prescription. As of September 2026, it breaks federal law to hand over a prescription-only drug when no valid prescription stands behind the order.^note
2. No real assessment. Be wary if all you do is tick boxes on an online form that no one follows up with questions. A proper assessment lets a clinician ask you more before prescribing. Prescribing from that kind of fixed form alone is unacceptable, according to the Federation of State Medical Boards, an umbrella body for the state boards that license doctors. That is guidance each state board adopts in its own way, not a federal law.^note
3. A “research use only” product meant for people. As of September 2026, FDA warning letters describe sermorelin sold that way for human use as an unapproved new drug.^note
4. A claim that compounded sermorelin is FDA-approved. As of September 2026, that claim is false because compounded drugs do not carry FDA approval.^note
5. A hidden pharmacy. If the service keeps quiet about which pharmacy prepares and ships the medicine, there is no licence you can check.
6. A drug code number used as proof of approval. An NDC (National Drug Code) number is an ID number a product gets in an FDA database. As of September 2026, the FDA says an NDC number does not show that a product has approval, and that using one to suggest approval is misleading.^note